Privia Health Group Inc

Privia Health Group Inc(PRVA)股票分析

$22.410

-0.466 (-2.08%)收盤時

Loading chart…
最高
22.880
開盤
22.690
成交量加權均價
22.56
成交量
669.36K
市值
2.04B
最低
22.390
成交金額
15.10M
企業價值/稅息折舊攤銷前利潤(TTM)
-6,436.01

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

AI 分析 of Privia Health Group Inc (PRVA)

買進

Privia Health Group Inc is a good buy right now due to its current price of $22.41, which is significantly below the analyst price target of $35, indicating a potential upside of 56%. Additionally, the company's recent earnings report showed a 12.4% year-over-year increase in practice collections, demonstrating strong operational performance. However, a risk to consider is the recent EPS surprise of -12.5%, which may affect investor sentiment.

估值指標

Privia Health Group Inc(PRVA)目前預期本益比為 17.27,5 年平均預期本益比為 60.08。

預期本益比

合理
5 年均值 P/E
60.08
目前P/E
17.27
高估
344.19
低估
-224.03

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
-145.65
目前EV/EBITDA
-6436.01
高估
1053.23
低估
-1344.52

預期股價營收比

低估
5 年均值 P/S
1.60
目前P/S
1.08
高估
2.10
低估
1.10

Alphio AI 對 PRVA 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%PRVA

$29.18

情境價格

基

基準

基準 · 50%PRVA

$27.83

情境價格

悲

悲觀

悲觀 · 25%PRVA

$24.83

情境價格

持有 PRVA 的大戶

V

Van Berkom and Associates Inc.

+ 持有PRVA

+0.46%

3個月報酬率

D

Durable Capital Partners, LP

+ 持有PRVA

-8.31%

3個月報酬率

事件時間軸

2026-08-06 (ET)

06:30:00

FY26 Consensus at $2.42, Adjusted EBITDA Expected in $145M-$155M Range

06:30:00

Company Reports Q2 Revenue of $632.6M

2026-05-27 (ET)

09:10:00

Privia Health Signs Agreement with NGBC to Enter New Jersey

2026-05-07 (ET)

06:20:00

Company Reports Q1 Revenue of $603.8M, Exceeds Consensus

2026-02-26 (ET)

06:30:00

Company Reports Q4 Revenue of $541.2M

資訊

PRVA 常見問題 —— 由 Alphio AI 解答

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

Privia Health Group Inc is a good buy right now due to its current price of $22.41, which is significantly below the analyst price target of $35, indicating a potential upside of 56%. Additionally, the company's recent earnings report showed a 12.4% year-over-year increase in practice collections, demonstrating strong operational performance. However, a risk to consider is the recent EPS surprise of -12.5%, which may affect investor sentiment.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易